Laird Norton Trust Company, LLC Gamida Cell Ltd. Transaction History

Laird Norton Trust Company, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 03, 2022	SELL	$1.73 - $4.29 $915,348 - $2.27 Million	-529,103 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$5.85 - $8.33 $3.1 Million - $4.41 Million	529,103 New	529,103 $3.39 Million

31.4K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Laird Norton Trust Company, LLC with notifications on news.